Cardlytics Stock Performance
| CDLX Stock | USD 0.92 0.06 7.03% |
The firm shows a Beta (market volatility) of 3.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardlytics will likely underperform. At this point, Cardlytics has a negative expected return of -0.69%. Please make sure to confirm Cardlytics' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Cardlytics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cardlytics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Is Cardlytics Inc. stock bottoming after sell off - Quarterly Trade Review Free Daily Entry Point Trade Alerts - newser.com | 11/17/2025 |
2 | 12 Communication Services Stocks Moving In Tuesdays Pre-Market Session - Benzinga | 12/16/2025 |
3 | Disposition of 14349 shares by Alexis DeSieno of Cardlytics subject to Rule 16b-3 | 12/31/2025 |
4 | Disposition of 8607 shares by Alexis DeSieno of Cardlytics at 1.17 subject to Rule 16b-3 | 01/05/2026 |
5 | Acquisition by David Evans of 1000000 shares of Cardlytics subject to Rule 16b-3 | 01/12/2026 |
6 | Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635 | 01/16/2026 |
7 | Cardlytics and Yext Head to Head Survey | 02/02/2026 |
| Begin Period Cash Flow | 91.8 M | |
| Total Cashflows From Investing Activities | -18.7 M |
Cardlytics | Build AI portfolio with Cardlytics Stock |
Cardlytics Relative Risk vs. Return Landscape
If you would invest 143.00 in Cardlytics on November 8, 2025 and sell it today you would lose (57.00) from holding Cardlytics or give up 39.86% of portfolio value over 90 days. Cardlytics is currently does not generate positive expected returns and assumes 5.6056% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Cardlytics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardlytics Target Price Odds to finish over Current Price
The tendency of Cardlytics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.92 | 90 days | 0.92 | about 91.37 |
Based on a normal probability distribution, the odds of Cardlytics to move above the current price in 90 days from now is about 91.37 (This Cardlytics probability density function shows the probability of Cardlytics Stock to fall within a particular range of prices over 90 days) .
Cardlytics Price Density |
| Price |
Predictive Modules for Cardlytics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardlytics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cardlytics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardlytics is not an exception. The market had few large corrections towards the Cardlytics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardlytics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardlytics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.12 | |
β | Beta against Dow Jones | 3.17 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.16 |
Cardlytics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardlytics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardlytics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardlytics generated a negative expected return over the last 90 days | |
| Cardlytics has high historical volatility and very poor performance | |
| Cardlytics has some characteristics of a very speculative penny stock | |
| Cardlytics has high likelihood to experience some financial distress in the next 2 years | |
| Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 278.3 M. Net Loss for the year was (189.3 M) with profit before overhead, payroll, taxes, and interest of 111.46 M. | |
| Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: Cardlytics and Yext Head to Head Survey |
Cardlytics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardlytics Stock often depends not only on the future outlook of the current and potential Cardlytics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardlytics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.4 M | |
| Cash And Short Term Investments | 65.6 M |
Cardlytics Fundamentals Growth
Cardlytics Stock prices reflect investors' perceptions of the future prospects and financial health of Cardlytics, and Cardlytics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardlytics Stock performance.
| Return On Equity | -3.41 | ||||
| Return On Asset | -0.09 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 222.72 M | ||||
| Shares Outstanding | 54.06 M | ||||
| Price To Earning | (3.47) X | ||||
| Price To Book | 2.15 X | ||||
| Price To Sales | 0.19 X | ||||
| Revenue | 278.3 M | ||||
| Gross Profit | 111.46 M | ||||
| EBITDA | (152.53 M) | ||||
| Net Income | (189.3 M) | ||||
| Cash And Equivalents | 157.04 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 221.65 M | ||||
| Debt To Equity | 0.42 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | (0.09) X | ||||
| Cash Flow From Operations | (8.82 M) | ||||
| Earnings Per Share | (2.14) X | ||||
| Market Capitalization | 46.75 M | ||||
| Total Asset | 392.71 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 29.03 M | ||||
| Current Asset | 81.93 M | ||||
| Current Liabilities | 52.77 M | ||||
About Cardlytics Performance
Evaluating Cardlytics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cardlytics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cardlytics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 69.28 | 72.74 | |
| Return On Tangible Assets | (0.98) | (1.03) | |
| Return On Capital Employed | (0.72) | (0.76) | |
| Return On Assets | (0.43) | (0.46) | |
| Return On Equity | (3.11) | (2.95) |
Things to note about Cardlytics performance evaluation
Checking the ongoing alerts about Cardlytics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardlytics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardlytics generated a negative expected return over the last 90 days | |
| Cardlytics has high historical volatility and very poor performance | |
| Cardlytics has some characteristics of a very speculative penny stock | |
| Cardlytics has high likelihood to experience some financial distress in the next 2 years | |
| Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 278.3 M. Net Loss for the year was (189.3 M) with profit before overhead, payroll, taxes, and interest of 111.46 M. | |
| Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: Cardlytics and Yext Head to Head Survey |
- Analyzing Cardlytics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardlytics' stock is overvalued or undervalued compared to its peers.
- Examining Cardlytics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardlytics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardlytics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardlytics' stock. These opinions can provide insight into Cardlytics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.